Plasma levels of nucleosomes and nucleosome-autoantibody complexes in murine lupus: Effects of disease progression and lipopolysaccharide administration

Arthritis and Rheumatism

Volumn 44, Issue 6, 2001, Pages 1320-1330

  Licht, Rudi ^a   Van Bruggen, Mieke C J ^a   Oppers Walgreen, Birgitte ^a   Rijke, Truus P M ^a   Berden, Jo H M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN; NUCLEOSOME ANTIBODY; UNCLASSIFIED DRUG;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; APOPTOSIS; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; KINETICS; MOUSE; NONHUMAN; NUCLEOSOME; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEINURIA; SYSTEMIC LUPUS ERYTHEMATOSUS;

AGE FACTORS; ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIGEN-ANTIBODY COMPLEX; CELL COUNT; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDES; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; MICE, INBRED MRL LPR; NUCLEOSOMES; THYMUS GLAND;

EID: 0034966564     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200106)44:6<1320::AID-ART224>3.0.CO;2-X     Document Type: Article

References (48)

1. Lupus nephritis. Nephrology forum
2. Polyclonal B cell activation in lupus-prone mice precedes and predicts the development of auto-immune disease
3. Nucleosomes and lupus nephritis
4. Apoptosis, nucleosomes, and nephritis in systemic lupus erythematosus: Editorial review
5. Autoimmune disease: A problem of defective apoptosis
6. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus
7. Nucleosome, a major immunogen for pathogenic autoantibody-inducing T cells of lupus
8. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation
9. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes
10. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus
11. Presence of nucleosome-restricted antibodies in patients with systemic lupus erythematosus
12. Antinucleosome antibodies and systemic lupus erythematosus
13. Genesis and evolution of anti-chromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen
14. Nephritogenic autoantibodies in lupus: Current concepts and continuing controversies
15. Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo
16. Significance of anti-nuclear and anti-extracellular matrix autoantibodies for albuminuria in MRL/1 mice: A longitudinal study on plasma and glomerular eluates
17. Nucleosomes and histones are present in glomerular deposits in human lupus nephritis
18. Mapping of linear histone regions exposed at the surface of the nucleosome in solution
19. Specificity of monoclonal antinucleosome auto-antibodies derived from lupus mice
20. Monoclonal antibody (WT 1) directed against a T cell surface glycoprotein: Characteristics and immunosuppressive activity
21. Antigen specificity of antinuclear antibodies complexed to nucleosomes determines glomerular basement membrane binding in vivo
22. Endogenous circulating DNA in systemic lupus erythematosus: Occurrence as multimeric complexes bound to histone
23. Detection of nucleosome-IgG immune complexes in ascites from mice transplanted with anti-DNA antibody-secreting hybridomas and in plasmas from MRL-lpr/lpr mice
24. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
25. An assay for the quantitative measurement of in vitro phagocytosis of early apoptotic thymocytes by resident peritoneal macrophages
26. Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus: Correlation with serum antinucleosome antibody titers and absence of clear association with disease activity
27. Structure and binding properties of monoclonal antibodies to core histones from autoimmune mice
28. Blood clearance kinetics and liver uptake of mononucleosomes in mice
29. Antibodies to histones in systemic lupus erythematosus and drug-induced lupus syndromes
30. Anti-heparan sulphate reactivity in sera from patients with systemic lupus erythematosus with renal or non-renal manifestations
31. Serologic markers of lupus nephritis in patients: Use of a tissue based ELISA and evidence for immunopathogenic heterogeneity
32. Higher anti-heparan sulphate reactivity during SLE exacerbations with renal manifestations: A long term prospective analysis
33. Heterogeneity and clinical significance of glomerular binding antibodies in systemic lupus erythematosus
34. Decrease of heparan sulfate staining in the glomerular basement membrane in murine lupus nephritis
35. Heparin and heparinoids prevent the binding of immune complexes containing nucleosomal antigens to the GBM and delay nephritis in MRL/l mice
36. Features of systemic lupus erythematosus in mice injected with bacterial lipopolysaccharide: Identification of circulating DNA and renal localization of DNA-anti-DNA complexes
37. Release of DNA in the circulating blood and induction of anti-DNA antibodies after injection of bacterial lipopolysaccharides
38. Anti-DNA antibodies can bind to the glomerulus via two distinct mechanisms
39. Bacterial lipopolysaccharide transforms mesangial into proliferative lupus nephritis without interfering with processing of pathogenic immune complexes in NZB/W mice
40. Long-lasting effects of bacterial lipopolysaccharide promote progression of lupus nephritis in NZB/W mice
41. Lipopolysaccharide from gram-negative bacteria enhances polyclonal B cell activation and exacerbates nephritis in MRL/lpr mice
42. Bacterial lipopolysaccharide enhances deposition of immune complexes and exacerbates nephritis in BXSB lupus-prone mice
43. Role of nucleosomes for induction and glomerular binding of autoantibodies in lupus nephritis
44. In vivo induction of apoptosis (programmed cell death) in mouse thymus by administration of lipopolysaccharide
45. Apoptosis and the thymic microenvironment in murine lupus
46. CD14-dependent clearance of apoptotic cells: Relevance to the immune system
47. Human CD14 mediates recognition and phagocytosis of apoptotic cells
48. LPS-binding proteins and receptors